What You Should Know:
– Healthcare technology company, Ro today announced the acquisition of Kit, an at-home diagnostics company that offers self-administered diagnostic tests, including finger prick blood assays, blood pressure tests, weight measurement tools, and more—all shipped directly to their door. Financial details of the acquisition were not disclosed.
– The acquisition of Kit will serve as a critical piece to Ro’s vertically integrated platform, which already offers nationwide telehealth, pharmacy, and in-home care services.
– Following the acquisition of Workpath and Modern Fertility, the acquisition makrs another step toward turning the home into the exam room of the future.
– In addition, the transaction adds CLIA-certified and CAP-certified lab infrastructure to Ro’s network, dramatically expanding our diagnostics capabilities. Kit enables Ro to expand to facilitate high-quality care for a much broader range of conditions that rely on patients’ diagnostic data.